IGC Pharma, Inc.
IGC
$0.3262
$0.01986.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 67.28% | 29.95% | -14.60% | 28.41% | -148.51% |
| Total Depreciation and Amortization | -1.88% | -8.23% | 4.52% | 7.19% | -6.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.22% | -29.58% | 32.24% | -26.52% | 714.64% |
| Change in Net Operating Assets | 50.00% | 51.61% | -58.11% | 1.39% | -6.12% |
| Cash from Operations | 17.01% | 38.44% | -19.35% | 65.33% | 3.70% |
| Capital Expenditure | 60.29% | 17.14% | -90.00% | -200.00% | 77.70% |
| Sale of Property, Plant, and Equipment | -- | 1,700.00% | -- | 133.33% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,200.00% | -148.15% | -232.14% | -34.20% | -66.67% |
| Cash from Investing | -70.49% | -190.28% | -2,520.00% | -33.47% | -258.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 100.00% | -- |
| Issuance of Common Stock | -- | -72.20% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 34,600.00% | -72.23% | 250,800.00% | 66,800.00% | -- |
| Foreign Exchange rate Adjustments | -100.00% | -10.00% | 100.00% | -81.82% | 107.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.71% | -121.34% | 142.50% | 89.71% | 1.79% |
